Patents Assigned to HUMANZYME INC.
  • Patent number: 9169309
    Abstract: The present technology relates to engineered human Fibroblast Growth Factor-2 (FGF2) proteins and methods of using the same. In particular, the methods and compositions relate to FGF2 mutants with increased thermostability compared to the wild-type protein and method for using the proteins in the culturing of embryonic stem cells.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: October 27, 2015
    Assignee: HUMANZYME INC.
    Inventor: Soon Seog Jeong